Mobile

Single Ascending Dose Study of SRA-444 in Healthy Subjects

Mise à jour : Il y a 4 ans
Référence : NCT00452504

  • | Pays :
  • Netherlands
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

This is a first-in-humans study of SRA-444. This study will provide an initial assessment of the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of SRA-444 (SR formulation) after administration of ascending single oral doses to healthy adult subjects.

Critère d'inclusion

  • Alzheimer Disease

Liens